Abstract
Background: Percutaneous coronary intervention (PCI) can induce vascular injury and inflammatory responses. miRNAs are involved in vascular homeostasis and repair processes, but their interactions with inflammatory factors after PCI are not yet fully defined.
Objectives: The objective of this study was to determine the changes in inflammatory factors in PCI patients and their correlation with the expression of specific miRNAs.
Methods: Patients undergoing PCI were selected as the observation group (AG), and healthy individuals undergoing physical examinations as the control group (BG). Inflammatory factors in the serumwere quantified adopting ELISA. RT-qPCR was utilized for measurement to assess the associations between inflammatory factors and miRNAs expression.
Results: IL-6, IL-10, IL-1β, and TNF-α were markedly elevated in the AG versus the BG; in the AG, the expression of miRNA-21 was significantly up-regulated, while the expression of miRNA-92a and miRNA-126 was significantly down-regulated (P < 0.05). Correlation analysis showed that the levels of IL-6, IL-10, IL-1β, and TNF-α were positively correlated with the expression of miRNA-21 and negatively correlated with the expression of miRNA-92a and miRNA-126.
Conclusion: Inflammatory responses are significantly activated in patients after PCI, accompanied by changes in miRNA expression profiles. Pro-inflammatory factors are positively associated with miRNA-21 and negatively associated with miRNA-92a and miRNA-126, reflecting their joint involvement in the damage and repair of blood vessels after surgery.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.